Pharmerging Market Report

Pharmerging Market Analysis By Product, By Region {Tier I (China), Tier II (India, Brazil, Russia, South Africa) Tier III (Argentina, Mexico, Poland, Turkey, Indonesia)}, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-2-68038-256-3
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Table of Contents

Chapter 1 Executive Summary
                  1.1 Market Snapshot
Chapter 2 Research Methodology
                  2.1 Information procurement
                  2.2 Information or Data Analysis
                  2.3 Market Formulation & Validation
Chapter 3 Pharmerging Market Variables, Trends & Scope
                  3.1 Market segmentation & scope
                      3.1.1 Market Driver Analysis
                          3.1.1.1 Increasing geriatric population
                          3.1.1.2 Increasing healthcare expenditure
                          3.1.1.3 Increasing chronic diseases
                      3.1.2 Market Restraint Analysis
                          3.1.2.1 Lack of insurance coverage
                  3.2 Penetration & growth prospect mapping: Molecule type
                  3.3 Pharmerging Market - SWOT Analysis, By Factor (political & legal, economic and technological)
                  3.4 Industry Analysis - Porter’s
                  3.5 Country Risk Analysis
                      3.5.1 Political Risks
                      3.5.2 Economic Risk
                      3.5.3 Demographic Risk
Chapter 4 Pharmerging Market Regional Estimates & Trend Analysis, By Service
                  4.1 Tier I
                      4.1.1 Reimbursement Policy
                      4.1.2 Manufacturing outlook
                      4.1.3 Disease prevalence
                  4.2 Tier II
                      4.2.1 India
                          4.2.1.1 Reimbursement Policy
                          4.2.1.2 Manufacturing Outlook
                          4.2.1.3 Disease Prevalence
                      4.2.2 Russia
                          4.2.2.1 Reimbursement Policies
                          4.2.2.2 Disease Prevalence
                      4.2.3 Brazil
                          4.2.3.1 Reimbursement Policies
                          4.2.3.2 Manufacturing Outlook
                          4.2.3.3 Disease Prevalence
                      4.2.4 South Africa
                          4.2.4.1 Reimbursement Policies
                          4.2.4.2 Healthcare Sector Statistics
                          4.2.4.3 Disease Prevalence
                  4.3 Tier III
                      4.3.1 Argentina
                          4.3.1.1 Reimbursement Providers
                          4.3.1.2 Healthcare Availability
                          4.3.1.3 Disease prevalence
                      4.3.2 Mexico
                          4.3.2.1 Healthcare Expenditure Trends
                          4.3.2.2 Medical Tourism
                          4.3.2.3 Disease Prevalence
                      4.3.3 Poland
                          4.3.3.1 Reimbursement Policy
                          4.3.3.2 Healthcare Statistics and Disease Burden
                      4.3.4 Turkey
                          4.3.4.1 Healthcare Policies
                          4.3.4.2 Disease Burden
                      4.3.5 Saudi Arabia
                          4.3.5.1 Healthcare Policies
                          4.3.5.2 Disease Burden
                      4.3.6 Algeria
                          4.3.6.1 Healthcare Services Outlook
                          4.3.6.2 Disease Burden
                      4.3.7 Thailand
                          4.3.7.1 Healthcare policies
                          4.3.7.2 Disease Burden
                      4.3.8 Indonesia
                          4.3.8.1 Healthcare Policies
                          4.3.8.2 Disease Burden
                      4.3.9 Egypt
                          4.3.9.1 Healthcare Policies
                          4.3.9.2 Disease Burden
                      4.3.10 Nigeria
                          4.3.10.1 Healthcare Policies
                          4.3.10.2 Disease Burden
                      4.3.11 Ukraine
                          4.3.11.1 Healthcare Policies
                          4.3.11.2 Disease Burden
                      4.3.12 Pakistan
                          4.3.12.1 Healthcare Policies
                          4.3.12.2 Disease Burden
Chapter 5 Competitive Landscape
                  5.1 Strategy framework
                  5.2 Company Profiles
                      5.2.1 Sanofi
                          5.2.1.1 Company overview
                          5.2.1.2 Financial Performance
                          5.2.1.3 Revenue by National Market
                          5.2.1.4 Product benchmarking
                          5.2.1.5 Strategic initiatives
                      5.2.2 Pfizer Inc.
                          5.2.2.1 Company overview
                          5.2.2.2 Financial Performance
                          5.2.2.3 Revenues by National Market
                          5.2.2.4 Product benchmarking
                          5.2.2.5 Strategic initiatives
                      5.2.3 AstraZeneca
                          5.2.3.1 Company overview
                          5.2.3.2 Financial performance
                          5.2.3.3 Revenues by National Market
                          5.2.3.4 Product benchmarking
                          5.2.3.5 Strategic initiatives
                      5.2.4 GlaxoSmithKline
                          5.2.4.1 Company overview
                          5.2.4.2 Financial performance
                          5.2.4.3 Revenues by National Market
                          5.2.4.4 Product benchmarking
                          5.2.4.5 Strategic initiatives
                      5.2.5 F.Hoffmann-La Roche Ltd
                          5.2.5.1 Company overview
                          5.2.5.2 Financial performance
                          5.2.5.3 Pharmaceutical division Revenues by National Market
                          5.2.5.4 Diagnostics division Revenues by National Market
                          5.2.5.5 Product benchmarking
                          5.2.5.6 Strategic initiatives
                      5.2.6 GE Healthcare
                          5.2.6.1 Company overview
                          5.2.6.2 Financial performance
                          5.2.6.3 Revenues by National Market
                          5.2.6.4 Product benchmarking
                          5.2.6.5 Strategic initiatives
                      5.2.7 Eli Lilly
                          5.2.7.1 Company overview
                          5.2.7.2 Financial performance
                          5.2.7.3 Revenues by National Market
                          5.2.7.4 Product benchmarking
                          5.2.7.5 Strategic initiatives
                      5.2.8 Medtronic
                          5.2.8.1 Company overview
                          5.2.8.2 Financial performance
                          5.2.8.3 Revenues by National Market
                          5.2.8.4 Product benchmarking
                          5.2.8.5 Strategic initiatives
                      5.2.9 Johnson and Johnson
                          5.2.9.1 Company overview
                          5.2.9.2 Financial performance
                          5.2.9.3 Revenues by National Market
                          5.2.9.4 Product benchmarking
                          5.2.9.5 Strategic initiatives
                      5.2.10 Abbott
                          5.2.10.1 Company overview
                          5.2.10.2 Financial performance
                          5.2.10.3 Revenues by National Market
                          5.2.10.4 Product benchmarking
                          5.2.10.5 Strategic initiatives


List of Tables

TABLE 1. Pharmerging Market by Region (2014 - 2025, USD Billion)
TABLE 2. Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 3. Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 4. Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 5. Tier 1/China Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 6. Tier 1/China Pharmerging Pharmaceuticals Market by Exclusivity (2014 - 2025, USD Billion)
TABLE 7. Tier 1/China Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 8. Tier 2 Pharmerging Market by Region (2014 - 2025, USD Billion)
TABLE 9. Tier 2 Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 10. Tier 2 Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 11. Tier 2 Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 12. Brazil Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 13. Brazil Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 14. Brazil Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 15. India Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 16. India Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 17. India Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 18. Russia Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 19. Russia Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 20. Russia Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 21. South Africa Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 22. South Africa Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 23. South Africa Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 24. Tier 3 Pharmerging Market by Region (2014 - 2025, USD Billion)
TABLE 25. Tier 3 Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 26. Tier 3 Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 27. Tier 3 Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 28. Argentina Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 29. Argentina Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 30. Argentina Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 31. Mexico Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 32. Mexico Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 33. Mexico Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 34. Poland Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 35. Poland Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 36. Poland Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 37. Turkey Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 38. Turkey Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 39. Turkey Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 40. Saudi Arabia Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 41. Saudi Arabia Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 42. Saudi Arabia Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 43. Ukraine Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 44. Ukraine Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 45. Ukraine Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 46. Algeria Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 47. Algeria Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 48. Algeria Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 49. Nigeria Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 50. Nigeria Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 51. Nigeria Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 52. Egypt Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 53. Egypt Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 54. Egypt Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 55. Pakistan Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 56. Pakistan Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 57. Pakistan Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 58. Thailand Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 59. Thailand Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 60. Thailand Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)
TABLE 61. Indonesia Pharmerging Market by Product (2014 - 2025, USD Billion)
TABLE 62. Indonesia Pharmerging Pharmaceuticals Market by Type (2014 - 2025, USD Billion)
TABLE 63. Indonesia Pharmerging Healthcare Products Market by Type (2014 - 2025, USD Billion)


List of Figures

FIG. 1 Market summary (USD Million), 2016
FIG. 2 Market research process
FIG. 3 Information Procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Country Risk Analysis, 2016
FIG. 16 Regional market place: Key takeaways
FIG. 17 Tier I market, 2014 - 2025
FIG. 18 Regional Market Share, 2016
FIG. 19 Tier II market, 2014 - 2025
FIG. 20 Regional Market Share, 2016
FIG. 21 India market, 2014 - 2025
FIG. 22 Disease prevalence
FIG. 23 Russia market, 2014 - 2025
FIG. 24 Brazil market, 2014 - 2025
FIG. 25 South Africa market, 2014 - 2025
FIG. 26 Tier III market, 2014 - 2025
FIG. 27 Regional Market Share, 2016
FIG. 28 Argentina market, 2014 - 2025
FIG. 29 Mexico market, 2014 - 2025
FIG. 30 Poland market, 2014 - 2025
FIG. 31 Turkey market, 2014 - 2025
FIG. 32 Saudi Arabia market, 2014 - 2025
FIG. 33 Algeria market, 2014 - 2025
FIG. 34 Thailand market, 2014 - 2025
FIG. 35 Indonesia market, 2014 - 2025
FIG. 36 Egypt market, 2014 - 2025
FIG. 37 Nigeria market, 2014 - 2025
FIG. 38 Ukraine market, 2014 - 2025
FIG. 39 Pakistan market, 2014 - 2025
FIG. 40 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.